Expression of the human mismatch repair gene hMSH2: A potential marker for urothelial malignancy

Cancer

Volumn 88, Issue 10, 2000, Pages 2333-2341

  Leach, Fredrick S ^a,b   Hsieh, Jer Tsong ^a   Molberg, Kyle ^a   Saboorian, M Hossein ^a   McConnell, John D ^a   Sagalowsky, Arthur I ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HMSH2; Immunohistochemistry; Mismatch repair; Reverse transcription polymerase chain reaction (RT PCR); Urothelial malignancy

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; BLADDER TUMOR; CLINICAL ARTICLE; DNA REPAIR; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR RECURRENCE; UROGENITAL TRACT TUMOR;

ADENOSINE TRIPHOSPHATASES; AGED; AGED, 80 AND OVER; BASE PAIR MISMATCH; CARCINOMA, TRANSITIONAL CELL; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0034657617     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000515)88:10<2333::AID-CNCR18>3.0.CO;2-Y     Document Type: Article

References (40)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
2. Sidransky D, Messing E. Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors. Urol Clin North Am 1992; 19:629-39.
3. Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME, Law MG. Allelotype of human bladder cancer. Cancer Res 1994;54:531-8.
4. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 1995;11:210-2.
5. Rosin MP, Cairns P, Epstein JI, Schoenberg MP, Sidransky D. Partial allelotype of carcinoma in situ of the human bladder. Cancer Res 1995;55:5213-6.
6. Sidransky D, von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, et al. Identification of p53 in bladder cancer and urine samples. Science 1991;252:706-9.
7. Logothetis CJ, Xu HJ, Ro JY, Hu SX, Sahin A, Ordonez N, et al. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 1992;84:1256-61.
8. Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen S-C, et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 1994;331:1259-64.
9. Messing EM. Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors. Semin Surg Oncol 1992;8:285-92.
10. Sato K, Moriyma M, Mori S, Saito M, Watanuki T, Terada K, et al. An immunohistological evaluation of c-erbB-2 gene product in patients with urinary bladder carcinoma. Cancer 1992;70:2493-6.
11. Lipponen P, Eskelinen M. Expression of epidermal growth factor receptor in bladder cancer, as related to established prognostic factors, oncoprotein expression, and long-term prognosis. Br J Cancer 1994;69:1120-2.
12. Jin T-X, Furihata M, Yamasaki I, Kamada M, Liang S-B, Ohtsuki Y, et al. Human mismatch repair gene (hMSH2) product expression in relation to recurrence of transitional cell carcinoma of the urinary bladder. Cancer 1999;85:478-84.
13. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin J-P, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
14. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
15. Ionov YM, Peinado A, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61.
16. Parsons R, Li G-M, Longley MJ, Fang W-H, Papadopolous N, Jen J, et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993;75:1227-36.
17. Umar A, Boyer JC, Thomas DC, Nguyen DC, Resinger JI, Boyd J, et al. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem 1994;269:14367-70.
18. Li GM, Modrich P. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human mutL homologs. Proc Natl Acad Sci USA 1995;92: 1950-4.
19. Kolodner R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev 1996;10:1433-42.
20. Modrich P, Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Ann Rev Biochem 1996;65:101-33.
21. Fishel R, Ewel A, Lee S, Lescoe MK, Griffith J. Binding of mismatched microsatellite DNA sequences by the MSH2 protein. Science 1994;266:1403-5.
22. Prolla TA, Pang Q, Alani E, Kolodner RD, Liskay RM. MLH1, PMS1 and MSH2 interactions during the initiation of DNA mismatch repair in yeast. Science 1994;265:1091-3.
23. Drummond JT, Li G, Longley MJ, Modrich P. Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science 1995;268:1909-12.
24. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
25. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al. Mutations of a mutS homolog in hereditary nonpolyposis colon cancer. Cell 1993;75:1215-25.
26. Liu B, Parsons RE, Hamilton SR, Petersen GM, Lynch HT, Watson P, et al. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 1994;54:4590-4.
27. Borresen A-L, Lothe RA, Meling GI, Lystad S, Morrison P, Lipford J, et al. Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet 1995;4:2065-72.
28. Liu B, Nicolaides NC, Markowitz S, Willson JKV, Parsons RE, Jen J, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995; 9:48-55.
29. Lynch HT, Ens JA, Lynch JF. The Lynch syndrome II and urologic malignancies. J Urol 1990;143:24-8.
30. Lynch PM, Cavalieri RJ, Boland CR. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gasteroenterology 1993;104:1535-49.
31. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-85.
32. Leach FS, Polyak K, Burrell M, Johnson KA, Hill D, Dunlop MG, et al. Expression of the mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res 1996;56:235-40.
33. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996;56:4836-40.
34. Lin X, Howell SB. Effect of loss of DNA mismatch repair on development of topotecan-, gemcitabine-, and paclitaxel-resistant variants after exposure to cisplatin. Mol Pharm 1999;56:390-5.
35. Humbert O, Fiumicino S, Aquilina G, Branch P, Oda S, Zijno A, et al. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents. Carcinogenesis 1999;20:205-14.
36. Gerdes J, Lemke H, Baisch H, Wacher HH, Schwab U, Stein H. Cell cycle proliferation-associated human nuclear antigen defined by the monoclonal antibody KI-67. J Immunol 1984;133:1710-5.
37. Wilson TM, Ewel A, Duguid JR, Eble JN, Lescoe MK, Fishel R, et al. Differential cellular expression of the human MSH2 repair enzyme in small and large intestine. Cancer Res 1995; 55:5146-50.
38. Gonzalez-Zulueta M, Ruppert JM, Tokino K, Tsai YC, Spruck CH, Miyao N, et al. Microsatellite instability in bladder cancer. Cancer Res 1993;53:5620-3.
39. Stein JP, Grossfeld GD, Ginsberg DA, Esrig D, Freeman JA, Figueroa AJ, et al. Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol 1998;160:645-59.
40. Suzuki T, Suzuki Y, Fujioka T. Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer. J Urol 1999;162:2217-20.